Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women

被引：0
|
作者：
Silverman, Daniel [1 ]
Lee, Soo [1 ]
Geist, Cheri [1 ]
Yang, Chine Ching [1 ]
Togawa, Kayo [2 ]
Katheria, Vani [2 ]
Hansen, Kurt [2 ]
Patel, Sunita [2 ]
Czernin, Johannes [1 ]
Hurria, Arti [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1803
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hormone therapy and brain structure in postmenopausal women
    Molano, Jennifer Rose V.
    NEUROLOGY, 2016, 87 (09) : E100 - E101
  • [42] Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
    Frost, M. L.
    Siddique, M.
    Blake, G. M.
    Moore, A. E.
    Marsden, P. K.
    Schleyer, P. J.
    Eastell, R.
    Fogelman, I.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (08) : 2107 - 2116
  • [43] Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
    M. L. Frost
    M. Siddique
    G. M. Blake
    A. E. Moore
    P. K. Marsden
    P. J. Schleyer
    R. Eastell
    I. Fogelman
    Osteoporosis International, 2012, 23 : 2107 - 2116
  • [44] Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy
    Tang, Shou-Ching
    ONCOLOGY, 2010, 79 (1-2) : 13 - 26
  • [45] REGIONAL ADIPOSE-TISSUE METABOLISM IN MEN AND POSTMENOPAUSAL WOMEN
    REBUFFESCRIVE, M
    LONNROTH, P
    MARIN, P
    WESSLAU, C
    BJORNTORP, P
    SMITH, U
    INTERNATIONAL JOURNAL OF OBESITY, 1987, 11 (04) : 347 - 355
  • [46] DOSE PROPORTIONALITY AND POPULATION CHARACTERISTICS OF ORAL FADROZOLE HYDROCHLORIDE, AN AROMATASE INHIBITOR, IN POSTMENOPAUSAL WOMEN
    KOCHAK, GM
    CHOI, RL
    ENTWISTLE, EA
    PHARMACEUTICAL RESEARCH, 1993, 10 (12) : 1760 - 1764
  • [47] IBISII: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
    Cuzick, Jack
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1377 - 1385
  • [48] The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
    Mouridsen, HT
    Robert, NJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) : 1678 - 1689
  • [49] Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial
    Kilbreath, Sharon
    Refshauge, Kathryn M.
    Beith, Jane
    Ward, Leigh
    Sawkins, Kate
    Paterson, Ross
    Clifton-Bligh, Philip
    Sambrook, Philip N.
    Simpson, Judy M.
    Nery, Liza
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 704 - 709
  • [50] Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 875 - 884
12345